Injectable Compounding Pharmacy Market
According to Intent Market Research, the Injectable Compounding Pharmacy Market is expected to grow from USD 1.4 billion in 2024-e at a CAGR of 7.6% to touch USD 2.3 billion by 2030. The Injectable Compounding Pharmacy Market is dominated by key players such as Fagron, Inc., PharMEDium Services, LLC (Medline), Clinical IQ, The Compounding Pharmacy of America, Crest Pharmaceuticals and Neutron Holdings, Inc. (PostScript).